12.000
+0,00%
2024-07-25
Fundamental Analysis
22 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -1235.6% | -378.0% | 1 / 3 | +9.7% | -15.36 pp | -11.19 pp | -2.3% | 0.00 | — | 31,3 | +9,7% | −3,8 | −1.235,6% | — | -24.35 | — |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 12.000 (close price on 2024-07-25)EPS (TTM): −384,9
Financial charts
1.Revenue & growth
VND bn31,3Q2/26
1.Revenue & growth
VND bn31,3Q2/26
2.Profit & growth
VND bn-3,82Q2/26
3.Profit mix (Penman)
VND bn-7,70Q2/26
4.Margins & cost structure
%30.0%Q2/26
5.Returns & cash cycle
% · days-5.8%Q2/26
6.Earnings quality & cash
VND bn5,83Q2/26
7.Asset structure
VND bn365Q2/26
8.Funding & debt health
VND bn · times365Q2/26
9.Revenue backlog
VND bn2,93Q2/26
10.Valuation
times · %-31,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-191Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
153%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26